Publications by authors named "Li-fa Wang"
Article Synopsis
- The study discusses a rare case where an intracranial epidermoid cyst transformed into malignant squamous cell carcinoma (SCC) in a 47-year-old woman, leading to severe neurological symptoms like double vision and memory loss.
- Whole exome sequencing was performed on the patient, revealing two significant genetic mutations in the GJB2 and TLR2 genes that may contribute to the development of the SCC.
- The findings highlight the potential importance of these genes in understanding and treating SCC and support whole exome sequencing as a valuable tool for identifying genetic factors in complex diseases.
[Values of Serum Ferritin, Folic Acid and Vitamin B in Treatment of Multiple Myeloma with Bortezomib Combined with Chemotherapy].
Zhongguo Shi Yan Xue Ye Xue Za Zhi
October 2024
Objective: To investigate the value of serum ferritin, folic acid and vitamin B in the treatment of multiple myeloma (MM) with bortezomib combined with chemotherapy.
Methods: Clinical data of 40 MM patients admitted to our hospital from January 2020 to August 2022 and 40 hematology outpatients during the same period were reviewed. All MM patients were treated with bortezomib combined with chemotherapy.
Objective: To observe the effect of electroacupuncture (EA) intervention at different time in a day on the expression of tyrosine hydroxylase (TH) and c-fos in the Nucleus Accumbens (NAc) so as to explore its mechanism underlying improvement of ketamine addiction.
Methods: A total of 56 Sprague-Dawley rats were randomized into normal control, normal saline (2 mL/kg), model and EA groups. The EA group was subdivided into Zi-Shi (23:00), Mao-Shi (05:00), Wu-Shi (11:00) and You-Shi (17: 00) subgroups.
Objective: To explore the morphological basis of electroacupuncture (EA) in relieving addiction of ketamine.
Methods: Forty Sprague-Dawley rats were randomized into normal control, normal saline (10 mL/kg), model and ketamine+ EA groups. Ketamine-addiction model was established by intraperitoneal administration of ketamine (100 mg/kg) , once a day for 7 days.